Edition:
United States

Search Results  for '600285.SS'

Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Henan Lingrui Pharmaceutical Co Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

24 Sep 2016 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - Henan Lingrui Pharmaceutical Co Ltd (600285-SH)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

27 Sep 2016 Thomson Reuters Stock Report 11 $25.00

Wright Investors Service Comprehensive Report for Henan Lingrui Pharmaceutical Co., Ltd.

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

14 Sep 2016 Wright Reports 65 $75.00

Henan Lingrui Pharmaceutical Co., Ltd. (600285) - Financial Analysis Review

Henan Lingrui Pharmaceutical Co., Ltd. (600285) - Financial Analysis Review Summary Henan Lingrui Pharmaceutical Co., Ltd. (L...

12 Sep 2016 GlobalData 28 $300.00

Henan Lingrui Pharmaceutical Co., Ltd.: Downgraded to Average

30 Aug 2016 Sadif Analytics Prime 3 $10.00

Henan Lingrui Pharmaceutical Co., Ltd.: Upgraded to Above Average

28 Jun 2016 Sadif Analytics Prime 3 $10.00

Henan Lingrui Pharmaceutical Co., Ltd. (600285) - Financial Analysis Review

Henan Lingrui Pharmaceutical Co., Ltd. (600285) - Financial Analysis Review Summary Henan Lingrui Pharmaceutical Co., Ltd. (L...

17 Jun 2016 GlobalData 29 $300.00

Thomson Reuters Stock Report - Henan Lingrui Pharmaceutical Co Ltd (600285-SH)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

10 May 2016 Thomson Reuters Stock Report 11 $25.00

Henan Lingrui Pharmaceutical Co., Ltd. (600285) - Financial Analysis Review

Henan Lingrui Pharmaceutical Co., Ltd. (600285) - Financial Analysis Review Summary Henan Lingrui Pharmaceutical Co., Ltd. (L...

14 Mar 2016 GlobalData 29 $300.00

Henan Lingrui Pharmaceutical Co., Ltd.: Upgraded to Average

09 Mar 2016 Sadif Analytics Prime 3 $10.00